日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF

虾类口服免疫疗法在二期临床试验中的结果:MOTIF

Jiang, Shirley Y; Cao, Shu; Martinez, Kristine; Sharma, Reyna; Raeber, Olivia; Fernandes, Andrea; Bogetic, Dinara; Kaushik, Abhinav; Gupta, Sheena; Manohar, Monali; Maeker, Holden T; Chin, Andrew R; Long, Andrew J; Feight, Catherine; Woch, Margaret; Nadeau, Kari C; Chinthrajah, R Sharon; Sindher, Sayantani B

A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods

使用生物制剂改善多种口服免疫疗法疗效的 II 期随机对照试验 (COMBINE):设计、原理和方法

Long, A J; Sindher, S; Martinez, K; Choi, J H; Albarran, M; Schuetz, J; Parry, A; Tang, J; Garcia Llorett, M; Zedeck, S S; Grissinger, A; Kiernan, E; Leonard, S; Raeber, O; Feight, C; Anderson, B; Sharma, R; Bogetic, D; Chin, A R; Woch, M; Poyser, J; Laurienzo Panza, J; Togias, A; Wheatley, L; Boyd, S; Galli, S J; Nadeau, K C; Chinthrajah, R S